Antibody Resource

Antibody Resource

This category compiles background information and best practices for antibody work. Topics include selection criteria, handling protocols, and other practical tips for research and clinical settings.

Posts on Antibody Resource

Antibody-Drug Conjugates: A Brief

Antibody-Drug Conjugates: A Brief

Explore ADCs, combining monoclonal antibodies with potent drugs for precision cancer treatment. Learn about key components, clinical applications, & future innovations.

Jul 24, 2024
Read time: 5 mins
Antibody Specificity and Selectivity for Precision in Research

Antibody Specificity and Selectivity for Precision in Research

Understand antibody specificity & selectivity for precision in research. Learn how to enhance assay accuracy by selecting antibodies with high target recognition & minimal cross-reactivity.

Jul 10, 2024
Read time: 4 mins
Sensitivity and Experimental Environments in Antibody Performance

Sensitivity and Experimental Environments in Antibody Performance

Explore how experimental conditions, antigen presentation, and buffer environments influence antibody sensitivity and performance in biomedical research assays.

Jul 08, 2024
Read time: 5 mins
Research-Use-Only (RUO) Biologics for Antibody In Vivo Research

Research-Use-Only (RUO) Biologics for Antibody In Vivo Research

Explore how RUO biologics support preclinical antibody research with accessible, high-quality tools. Learn about their development, quality control, and applications.

Jul 04, 2024
Read time: 5 mins
Immune Checkpoint Inhibitors and Antibody Therapeutics: A Paradigm Shift in Cancer Treatment

Immune Checkpoint Inhibitors and Antibody Therapeutics: A Paradigm Shift in Cancer Treatment

Discover how immune checkpoint inhibitors like PD-1 & CTLA-4 blockers are transforming cancer treatment. Learn about synergies with antibody therapeutics.

Jun 28, 2024
Read time: 4 mins
Types of Payloads for Antibody-Drug Conjugates (ADCs)

Types of Payloads for Antibody-Drug Conjugates (ADCs)

Explore the diverse payloads used in ADCs, including microtubule inhibitors, DNA-damaging agents, & topoisomerase inhibitors, driving targeted cancer therapies.

Jun 17, 2024
Read time: 4 mins
Multi-Payload Antibody–Drug Conjugates

Multi-Payload Antibody–Drug Conjugates

Discover how multi-payload ADCs enhance cancer therapy by combining diverse cytotoxic agents, improving efficacy, overcoming resistance, and expanding therapeutic potential.

Jun 14, 2024
Read time: 5 mins
What Are Antibody Mimetics?

What Are Antibody Mimetics?

Discover antibody mimetics, engineered proteins like DARPins & affibodies, offering stability, small size, & versatility for therapeutic, diagnostic, & research applications.

Jun 07, 2024
Read time: 4 mins
Antibody Basics: Part 9 - Therapeutic targets - Autoimmune Diseases

Antibody Basics: Part 9 - Therapeutic targets - Autoimmune Diseases

Learn how antibody drugs target autoimmune diseases by blocking TNF-α, IL-6, & BAFF. Explore therapies like adalimumab & belimumab to manage inflammation & regulate immunity.

Jun 03, 2024
Read time: 10 mins
Antibody-Antibiotic Conjugates (AACs) in the Fight Against Bacterial Infections

Antibody-Antibiotic Conjugates (AACs) in the Fight Against Bacterial Infections

Discover how antibody-antibiotic conjugates (AACs) target resistant bacteria, combining mAb precision & antibiotic power to tackle infections like MRSA effectively.

May 31, 2024
Read time: 4 mins
Computational Design of Antibodies for Drug Discovery

Computational Design of Antibodies for Drug Discovery

Discover how AI and computational methods are revolutionizing antibody design, enhancing binding affinity, specificity, and therapeutic potential in drug discovery.

May 27, 2024
Read time: 5 mins
Antibody Basics: Part 8 - Therapeutic targets - Oncology: What is cancer immunotherapy?

Antibody Basics: Part 8 - Therapeutic targets - Oncology: What is cancer immunotherapy?

Discover cancer immunotherapy techniques like monoclonal antibodies, checkpoint inhibitors, & ADCs. Learn how targeted delivery & tumor selectivity improve cancer treatment.

May 24, 2024
Read time: 10 mins

Keep yourself updated with Biointron Insights

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.